Searchable abstracts of presentations at key conferences in endocrinology

ea0056p36 | Adrenal cortex (to include Cushing's) | ECE2018

Hypoaldosteronism induced by trimethroprim: hyponatremia is frequent

Herraiz Lorea , Azcutia Ane , Santiago Alejandro , Miguel Paz de , Crespo Irene , Cuesta Martin , Jimenez Ines , Calle Alfonso , Runkle Isabelle

Introduction: Hypoaldosteronism is characterized by the development of hyperkalemia, but can also induce hypovolemic hyponatremia. Trimethroprim can cause hypoaldosteronism through mineralocorticoid resistance. That hypoaldosteronism can induce hyponatremia in absence of Addison’s disease has been questioned. We studied the electrolyte disturbances found following initiation of trimetroprim therapy.Material and methods: Retrospective, analytical. La...

ea0056p104 | Clinical case reports - Pituitary/Adrenal | ECE2018

A new gene – TMEM127 – in familial pheochromocytoma/paraganglioma syndromes

Ventura Mara , Paiva Isabel , Melo Miguel , Lages Adriana , Oliveira Diana , Martins Diana , Cunha Nelson , Fadiga Lucia , Catarino Diana , Carrilho Francisco

Introduction: Pheochromocytomas are catecholamine-producing tumors originated from the chromaffin cells of the adrenal medulla. Although usually sporadic, this tumors could be associated with germline mutations in about 40% of cases. TMEM127 has recently been identified as a novel gene conferring increased susceptibility to pheochromocytoma.Case report: A 42-year-old woman was referred to our Hospital to perform a right adrenalectomy for pheochromocytoma...

ea0056p245 | Calcium & Vitamin D metabolism | ECE2018

Impact of vitamin D status in clinical, biochemical, radiological and pathological parameters in primary hyperparathyroidism

Iglesias Paloma , Gutierrez Sonsoles , Barba Raquel , Delgado Miguel Angel , Duran Manuel , Vazquez Clotilde , Guijarro Guadalupe , Pavon Isabel

To determine the effects of 25-hydroxyvitamin D (25-OHD) status on parathyroid adenoma weight, clinical, radiological and biochemical phenotype in patients with primary hyperparathyroidism (HPTP) were studied.Methods: Eighty-two patients with pHPT who underwent surgical treatment and in whom the presence of parathyroid adenoma were confirmed histopathologically were studied retrospectively. Patients were divided into 2 groups: group A patients with 25-OH...

ea0056p362 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Is it useful the O’Sullivan test ≥200 to diagnose gestational diabetes mellitus (GDM)?

Molina-Vega Maria , Picon-Cesar Maria Jose , Hernandez-Garcia Carmen , Damas-Fuentes Miguel , Diaz-Perdigones Cristina , Tinahones-Madueno Francisco

Introduction: A two-step approach is usually used to diagnose GDM. At 24–28 weeks of pregnancy, a 50 g 1-hour glucose or O’Sullivan test is performed. If it is positive (≥140 mg/dl), it is followed by a 100 g-3 hours-Oral Glucose Tolerance Test (OGTT) which is considered positive if at least two or more values are ≥ of reference values (105-190-165-145 mg/dl). Despite it is not include in any clinical practice guideline, sometimes the 100 g OGTT is obviat...

ea0056p510 | Diabetes therapy | ECE2018

Psychopathological determinants of enhanced quality of life in continuous subcutaneous insulin infusion therapy

Pereira Miguel , Goncalves Ana , Neves Celestino , Oliveira Sofia , Esteves Cesar , Arteiro Cristina , Costa Anabela , Redondo Carmo , Carvalho Davide

Introduction: Scientific progress allowed an evolution on the therapeutic of diabetes mellitus. Continuous subcutaneous insulin infusion therapy (CSII) is one good example, but, beside patients motivation little is known about other psychological factors of success in this therapeutic and how they contribute to quality of life (QoL).Objectives: Determining some psychopathological predictors of CSII satisfaction and QoL improvement in patients on CSII the...

ea0056p805 | Pituitary - Clinical | ECE2018

Long-term outcomes of different treatments for cushing disease: a retrospective study

Molero Inmaculada Gonzalez , Abuin Jose , Marin Monserrat Gonzalo , Doulatram Viyei , Arnes Juan Garcia , Arraez Miguel Angel , Olveira Gabriel

Introduction: Cushing disease (CD) results from excessive exposure to glucocorticoids caused by an adrenocorticotropic hormone–secreting pituitary tumor. Inadequately treated CD is associated with significant morbidity and elevated mortality.Objetive: The study purpose was to describe the long term treatment outcomes for CD patients in our hospital.Methods: Retrospective analysis of the records of 36 patients with Cushing dise...

ea0056p846 | Pituitary - Clinical | ECE2018

The use of colonoscopic screening in acromegaly in our everyday practice revisited: how compliant with guidelines have we been?

Bilbao Ismene , Egana Nerea , Ciriza Maite Perez de , Olaizola Izaskun , Garcia Cristina , Agea Leire , Aranburu Maite , Yoldi Alfredo , Goena Miguel

Introduction: Although it has been suggested that there is a strong association between acromegaly and premalignant colonic lesions and colon cancer, it seems that in real – life practice the adherence to ACRO colonoscopy guidelines might be lower than expected (as recently shown by M.Parolin et cols).Methods: We retrospectively reviewed the case records of the 54 patients with acromegaly seen in our center since 1994.We analyzed the findings of 27 ...

ea0056p963 | Male Reproduction | ECE2018

Hypogonadism and mortality in type 2 diabetic men

Corrales Juan Jose , Herrero Ana , Caceres Rocio , Sanchez Ana Isabel , Marcos Miguel , Recio Jose Maria , Miralles Jose Manuel

Introduction: Low testosterone serum levels are associated with increased mortality in non-diabetic males. However, knowledge about the association between male hypogonadism and mortality among type 2 diabetic (T2DM) men is limited due to short follow-up periods in the few existing studies.Objective: To assess the association between hypogonadism and mortality in diabetic men.Material and methods: 263 unselected men with T2DM (mean...

ea0073pep8.5 | Presented ePosters 8: Pituitary and Neuroendocrinology | ECE2021

Osilodrostat provides sustained control of urinary free cortisol in patients with Cushing’s disease: final results from a prospective, open-label study (LINC 2)

Fleseriu Maria , Biller Beverly , Bertherat Jerome , Young Jacques , Arnaldi Giorgio , O’Connell Paul , Izquierdo Miguel , Pedroncelli Alberto , Pivonello Rosario

IntroductionThe oral 11β-hydroxylase inhibitor, osilodrostat, normalized mean urinary free cortisol (mUFC) in 79% (15/19) of patients with Cushing’s disease at the end of the 22-week core LINC 2 study. Long-term efficacy and safety data following an optional extension phase are reported here.MethodsPatients with clinical benefit at week 22 could continue receiving osilodrostat during the extension; ...

ea0073aep110 | Calcium and Bone | ECE2021

Is necessary long-term follow-up of all patients with primary sporadic hyperparathyroidism undergoing parathyroidectomy?

Castro Ana , Cruz Andrea , Rocío Revuelta , Vicente Almudena , Sastre Julia , Castro Enrique , Mollejo Manuela , Carrasco Miguel

IntroductionPost parathyroidectomy cure in primary hyperparathyroidism (PHPT) is defined as normocalcemia six months after surgery. The frequency of persistent or recurrent post-surgical disease according to lengthy follow-up studies varies between 1% and 14%.ObjectiveTo determine if there is a subset of patients with cure criteria 6–12 months after parathyroidectomy that would not require long-term foll...